Berberine Mediates Exosomes Regulating the Lipid Metabolism Pathways to Promote Apoptosis of RA-FLS Cells

Sifan Guo, Zhibo Wang, Dandan Xie, Ying Cai, Yan Wang, Xian Wang, Qiang Yang, Aihua Zhang, Shi QiuPharmaceuticals 2024 · DOI

TL;DR

This study investigates how berberine, a natural compound, combats rheumatoid arthritis (RA) by influencing the lipid metabolism within exosomes released by RA fibroblast-like synoviocytes (RA-FLS). By identifying key lipid biomarkers in these exosomes and analyzing their metabolic pathways, the research reveals berberine's potential to induce apoptosis in RA-FLS cells and offers a novel therapeutic avenue for RA.

What Problem Does This Paper Address?

Rheumatoid arthritis (RA) is a chronic autoimmune disease causing joint inflammation, damage, and functional impairment. A key player in RA pathogenesis is the overproliferation of fibroblast-like synoviocytes (FLS) in the joint lining, which contributes to persistent inflammation. While conventional treatments exist, they often come with significant side effects. Traditional Chinese Medicine offers complementary approaches, and this paper focuses on berberine, a compound with known anti-inflammatory properties, to understand its mechanism in RA. Specifically, the study aims to uncover how berberine might exert its therapeutic effects by modulating the contents of exosomes, which are tiny vesicles released by cells that play a crucial role in intercellular communication and can carry disease-specific information. The challenge is to pinpoint the exact molecular mechanisms by which berberine influences these exosomes to combat RA.

Methods

The researchers employed a multi-pronged approach:

  • Cell Culture and Treatment: RA-FLS cells were cultured and treated with varying concentrations of berberine, along with TNF-α (a pro-inflammatory cytokine), to mimic RA conditions.
  • Apoptosis Assays: Flow cytometry and confocal laser scanning microscopy were used to assess the extent to which berberine induced apoptosis (programmed cell death) in RA-FLS cells.
  • Exosome Isolation and Lipid Metabolomics: Exosomes were isolated from the treated RA-FLS cells. Lipid metabolomics technology was then applied to comprehensively analyze the lipid composition of these exosomes.
  • Bioinformatic Analysis: The identified lipid biomarkers were analyzed using various databases and platforms (e.g., MetaboAnalyst, BioDeep) to understand their involvement in metabolic pathways and their correlation with RA. This included Principal Component Analysis (PCA) and Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA) for pattern recognition.

Datasets

Not explicitly detailed as distinct datasets for training or evaluation in the traditional machine learning sense. The study utilizes:

  • Cellular Exosomes: Exosomes isolated from cultured RA-FLS cells treated with berberine or a control.
  • Public Databases: Databases such as KEGG, SMPDB, and RaMP-DB were used for enrichment analysis and pathway mapping of the identified lipid biomarkers.

Key Insights and Ideas

  • Berberine Induces RA-FLS Apoptosis: The study provides strong evidence that berberine can significantly promote apoptosis in RA-FLS cells, a crucial step in reducing the inflammatory burden in RA.
  • Exosomes as Mediators: The research highlights the critical role of exosomes in mediating berberine's effects. Berberine doesn't just act directly on the cells; it alters the cargo within the exosomes released by these cells.
  • Lipid Metabolism is Key: The analysis revealed that berberine's influence on RA-FLS exosomes is largely mediated through the regulation of lipid metabolism pathways. This suggests that targeting lipid pathways within exosomes could be a novel therapeutic strategy.
  • Identification of Novel Biomarkers: The study identified 11 specific lipid biomarkers within the exosomes that are closely associated with RA and are modulated by berberine treatment. These could potentially serve as diagnostic or prognostic markers.
  • PPARY-NF-κB Pathway Involvement: A significant finding is that berberine appears to influence the PPARY-NF-κB complex, a critical pathway in inflammation and cell proliferation. By up-regulating certain lipids (like LPE), berberine might disrupt this complex, thereby inhibiting inflammation.

Key Results

  • Berberine demonstrated a dose-dependent promotion of TNF-α-induced apoptosis in RA-FLS cells.
  • The study identified 11 core lipid biomarkers in RA-FLS exosomes that were differentially regulated by berberine treatment.
  • These biomarkers are primarily involved in pathways such as glycerophospholipid metabolism, unsaturated fatty acid biosynthesis, and fatty acid degradation.
  • Berberine's therapeutic effect is linked to its ability to modulate the PPARY-NF-κB complex, influence CREB and EGR-1 expression, and affect cellular phagocytosis.

Limitations and Future Work

  • In Vitro Study: The study was conducted in vitro using cell cultures. While promising, these findings need to be validated in in vivo animal models and eventually in human clinical trials to confirm efficacy and safety.
  • Complexity of Exosomal Cargo: While lipidomics was performed, exosomes contain a complex mix of molecules (proteins, RNA). Future work could explore how berberine affects these other components and their synergistic roles.
  • Specific Mechanism of LPE Regulation: The paper suggests berberine up-regulates LPE, but the precise molecular mechanism by which berberine achieves this needs further elucidation.
  • Broader Therapeutic Potential: The authors suggest that berberine, delivered via exosomes or as a drug delivery system, could be an effective therapeutic agent for RA, opening avenues for developing new drug formulations.

Summary updated

Abstract

<b>Objectives</b>: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint damage and commonly linked to symptoms such as inflammation, swelling, and pain. Traditional Chinese Medicine offers complementary and integrative approaches in the management of rheumatoid arthritis, potentially providing additional options that may help address treatment challenges and enhance overall patient care. This paper explores the mechanism of action of berberine from the perspective of cellular exosomes by mediating exosomal contents and thus treating RA. <b>Methods</b>: With the help of flow cytometry and confocal laser scanning microscope, it was determined that berberine promotes apoptosis in RA-FLS cells, and then lipid metabolomics technology was applied to screen and characterize the exosomes of RA-FLS cells to identify lipid core biomarkers closely related to RA, which were then projected into various databases for comprehensive analysis. <b>Results</b>: The data analysis showed that berberine could call back 11 lipid core biomarkers closely associated with RA, and interactive visualization of the database revealed that these markers were mainly focused on lipid metabolism aspects such as fatty acid elongation, degradation, and biosynthesis, as well as the biosynthesis of unsaturated fatty acids or PPARA activation of gene expression, PPARα's role in lipid metabolism regulation, glycerophospholipid metabolism, mitochondrial fatty acid oxidation disorders, and organelle biogenesis and maintenance. <b>Conclusions</b>: Berberine exerts its therapeutic effect on RA by mediating exosomal contents and thus regulating multiple lipid-related biological pathways, affecting the PPARγ-NF-κB complex binding rate, CREB and EGR-1 expression, cellular phagocytosis, and other aspects needed to inhibit proliferation and inflammatory responses in RA-FLS. This study offers a research foundation for exploring the mechanism of action of berberine in the treatment of RA.
BibTeX
@inproceedings{guo2024berberine,
  author = {Sifan Guo and Zhibo Wang and Dandan Xie and Ying Cai and Yan Wang and Xian Wang and Qiang Yang and Aihua Zhang and Shi Qiu},
  title = {{Berberine Mediates Exosomes Regulating the Lipid Metabolism Pathways to Promote Apoptosis of RA-FLS Cells}},
  booktitle = {Pharmaceuticals},
  year = {2024},
  doi = {10.3390/ph17111509},
}
Figure